Your browser doesn't support javascript.
loading
Classification of current anticancer immunotherapies.
Galluzzi, Lorenzo; Vacchelli, Erika; Bravo-San Pedro, José-Manuel; Buqué, Aitziber; Senovilla, Laura; Baracco, Elisa Elena; Bloy, Norma; Castoldi, Francesca; Abastado, Jean-Pierre; Agostinis, Patrizia; Apte, Ron N; Aranda, Fernando; Ayyoub, Maha; Beckhove, Philipp; Blay, Jean-Yves; Bracci, Laura; Caignard, Anne; Castelli, Chiara; Cavallo, Federica; Celis, Estaban; Cerundolo, Vincenzo; Clayton, Aled; Colombo, Mario P; Coussens, Lisa; Dhodapkar, Madhav V; Eggermont, Alexander M; Fearon, Douglas T; Fridman, Wolf H; Fucíková, Jitka; Gabrilovich, Dmitry I; Galon, Jérôme; Garg, Abhishek; Ghiringhelli, François; Giaccone, Giuseppe; Gilboa, Eli; Gnjatic, Sacha; Hoos, Axel; Hosmalin, Anne; Jäger, Dirk; Kalinski, Pawel; Kärre, Klas; Kepp, Oliver; Kiessling, Rolf; Kirkwood, John M; Klein, Eva; Knuth, Alexander; Lewis, Claire E; Liblau, Roland; Lotze, Michael T; Lugli, Enrico.
Affiliation
  • Galluzzi L; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France.
  • Vacchelli E; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France.
  • Bravo-San Pedro JM; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France.
  • Buqué A; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France.
  • Senovilla L; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France.
  • Baracco EE; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France.
  • Bloy N; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France.
  • Castoldi F; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France. Sotio a.c., Prague, Czech Re
  • Abastado JP; Pole d'innovation thérapeutique en oncologie, Institut de Recherches Internationales Servier, Suresnes, France.
  • Agostinis P; Cell Death Research and Therapy (CDRT) Laboratory, Dept. of Cellular and Molecular Medicine, University of Leuven, Leuven, Belgium.
  • Apte RN; The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Aranda F; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Group of Immune receptors of the Innate and Adaptive System, Institut d'Investigacions Biomédiques August Pi
  • Ayyoub M; INSERM, U1102, Saint Herblain, France. Institut de Cancérologie de l'Ouest, Saint Herblain, France.
  • Beckhove P; Translational Immunology Division, German Cancer Research Center, Heidelberg, Germany.
  • Blay JY; Equipe 11, Centre Léon Bérard (CLR), Lyon, France. Centre de Recherche en Cancérologie de Lyon (CRCL), Lyon, France.
  • Bracci L; Dept. of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
  • Caignard A; INSERM, U1160, Paris, France. Groupe Hospitalier Saint Louis-Lariboisière - F. Vidal, Paris, France.
  • Castelli C; Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Cavallo F; Molecular Biotechnology Center, Dept. of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Celis E; Cancer Immunology, Inflammation and Tolerance Program, Georgia Regents University Cancer Center, Augusta, GA, USA.
  • Cerundolo V; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Clayton A; Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK. Velindre Cancer Centre, Cardiff, UK.
  • Colombo MP; Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Coussens L; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Dhodapkar MV; Sect. of Hematology and Immunobiology, Yale Cancer Center, Yale University, New Haven, CT, USA.
  • Eggermont AM; Gustave Roussy Cancer Campus, Villejuif, France.
  • Fearon DT; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
  • Fridman WH; INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie/Paris VI, Paris, France. Equipe 13, Centre de Recherche des Cordeliers, Paris, France.
  • Fucíková J; Sotio a.c., Prague, Czech Republic. Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.
  • Gabrilovich DI; Dept. of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Galon J; INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie/Paris VI, Paris, France. Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France.
  • Garg A; Cell Death Research and Therapy (CDRT) Laboratory, Dept. of Cellular and Molecular Medicine, University of Leuven, Leuven, Belgium.
  • Ghiringhelli F; INSERM, UMR866, Dijon, France. Centre Georges François Leclerc, Dijon, France. Université de Bourgogne, Dijon, France.
  • Giaccone G; Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Gilboa E; Dept. of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA.
  • Gnjatic S; Sect. of Hematology/Oncology, Immunology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Hoos A; Glaxo Smith Kline, Cancer Immunotherapy Consortium, Collegeville, PA, USA.
  • Hosmalin A; Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. INSERM, U1016, Paris, France. CNRS, UMR8104, Paris, France. Hôpital Cochin, AP-HP, Paris, France.
  • Jäger D; National Center for Tumor Diseases, University Medical Center Heidelberg, Heidelberg, Germany.
  • Kalinski P; Dept. of Surgery, University of Pittsburgh, Pittsburgh, PA, USA. University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA. Dept. of Immunology and Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Kärre K; Dept. of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
  • Kepp O; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
  • Kiessling R; Dept. of Oncology, Karolinska Institute Hospital, Stockholm, Sweden.
  • Kirkwood JM; University of Pittsburgh Cancer Institute Laboratory, Pittsburgh, PA, USA.
  • Klein E; Dept. of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
  • Knuth A; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Lewis CE; Academic Unit of Inflammation and Tumour Targeting, Dept. of Oncology, University of Sheffield Medical School, Sheffield, UK.
  • Liblau R; INSERM, UMR1043, Toulouse, France. CNRS, UMR5282, Toulouse, France. Laboratoire d'Immunologie, CHU Toulouse, Université Toulouse II, Toulouse, France.
  • Lotze MT; Dept. of Surgery, University of Pittsburgh, Pittsburgh, PA, USA. University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA.
  • Lugli E; Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Institute, Rozzano, Italy.
Oncotarget ; 5(24): 12472-508, 2014 Dec 30.
Article in En | MEDLINE | ID: mdl-25537519
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy / Neoplasms Limits: Animals / Humans Language: En Journal: Oncotarget Year: 2014 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy / Neoplasms Limits: Animals / Humans Language: En Journal: Oncotarget Year: 2014 Document type: Article Affiliation country: France Country of publication: United States